11th Annual Schizophrenia Education Day: How Recent Advances in Treatment Can Help Improve the Lives of Patients and Their Families
The Massachusetts General Hospital Department of Psychiatry invites you to attend the November symposium 11th Annual Schizophrenia Education Day: How Recent Advances in Treatment Can Help Improve the Lives of Patients and their Families.
Now in its 11th year, this exciting event will offer an update on new research findings and important clinical topics for patients and their families with schizophrenia. Participants will learn about social cognition and emotional processing as it relates to schizophrenia. Additionally, this program will feature an update on the role of novel treatments such as folic acid, and current clinical trials and innovative findings focusing on prevention. Finally, the expert faculty will discuss recovery-based group therapy as a means of treatment and the importance of integrated psychiatric care.
These interactive lectures represent a patient-oriented yet scientifically-based program that will give you straightforward, practical, cutting-edge information about the treatment of schizophrenia. This event will also include a patient panel which will provide a first-hand account of schizophrenia and the recovery process. We are grateful to these individuals for sharing their stories publicly and contributing their time to help others recovering from schizophrenia. We hope this program helps you and your family in the journey toward wellness.
About the Massachusetts General Hospital Department of Psychiatry
The Department of Psychiatry was established in 1934. In the course of seven decades, its scientists and clinicians have made significant contributions to the understanding and treatment of mental health disorders. Today, the department includes more than 600 affiliated psychiatrists and psychologists and has the largest clinical research program in the hospital, which includes research in neuroscience, genetics, and the assessment of new and established treatments for mental health disorders.
The Schizophrenia Clinical and Research Program at the Massachusetts General Hospital seeks to improve the quality of life for people with this potentially disabling, chronic illness. The program’s mission is to provide safe, effective, state-of-the-art treatment; facilitate early detection of schizophrenia; and understand the neurobiological basis of schizophrenia. The Annual Schizophrenia Education Day is part of the program’s educational outreach to individuals affected by the disorder and their families and friends. Through these public education programs, we aim to instill hope, communicate that schizophrenia is a treatable disorder, and provide knowledge that can improve functioning, health, and quality of life.
First-episode and Early Psychosis Program (FEPP) is one of more than 50 specialty clinical and research programs in the Department of Psychiatry at Massachusetts General Hospital. It offers highly specialized evaluation, treatment and education for people in the early stages of schizophrenia or who may be experiencing psychosis for the first time. Early intervention is the core of the program’s mission. Research shows that early diagnosis and treatment can help people recover from their illness more quickly. It can also lessen the problems typically associated with untreated psychosis, such as unemployment, substance abuse, hospitalization, disruption to relationships, law-breaking and suicidal behavior. This program offers state-of-the-art medical and psychological evaluation, medication treatment, education and family support, cognitive behavioral therapy, a form of talk therapy, and research-based care.
The MGH Psychiatry Academy (MGH-PA) was launched in 2005 to bring high quality continuing medical education to psychiatrists, primary care doctors, psychologists, social workers, and other health professionals around the world through live programming and the Internet. Since 2008 the MGH-PA has had more than 35,000 healthcare providers participate in live symposia and on-line activities. In 2010, the MGH-PA assumed responsibility for patient education programs that were formerly provided by the Mood and Anxiety Disorders Institute (MADI) Resource Center. The MGH-PA is now providing education for individuals, families, non-professional caregivers, and the community about mental health, translating the latest research advances into practical information to help people work with their doctors toward the most accurate diagnosis and the best possible treatment results.